Abbreviations:
eMC, electronic Medicines Compendium; GB, Great Britian; NI, Northern Ireland; SPC, Summary of Product Characteristics; PIL, Patient Information Leaflet
Omjjara is a registered trademark of the GlaxoSmithKline group of companies
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of this medicine.
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk for how to report side effects. Adverse events can also be reported to GSK Limited on +44 (0) 800 221 441 or UKSafety@gsk.com
